280 related articles for article (PubMed ID: 29735685)
1. Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.
Brynildsrud OB; Eldholm V; Bohlin J; Uadiale K; Obaro S; Caugant DA
Proc Natl Acad Sci U S A; 2018 May; 115(21):5510-5515. PubMed ID: 29735685
[TBL] [Abstract][Full Text] [Related]
2. Emergence of epidemic Neisseria meningitidis serogroup C in Niger, 2015: an analysis of national surveillance data.
Sidikou F; Zaneidou M; Alkassoum I; Schwartz S; Issaka B; Obama R; Lingani C; Tate A; Ake F; Sakande S; Ousmane S; Zanguina J; Seidou I; Nzeyimana I; Mounkoro D; Abodji O; Wang X; Taha MK; Moulia-Pelat JP; Pana A; Kadade G; Ronveaux O; Novak R; Oukem-Boyer OOM; Meyer S;
Lancet Infect Dis; 2016 Nov; 16(11):1288-1294. PubMed ID: 27567107
[TBL] [Abstract][Full Text] [Related]
3. Whole-Genome Characterization of Epidemic Neisseria meningitidis Serogroup C and Resurgence of Serogroup W, Niger, 2015.
Kretz CB; Retchless AC; Sidikou F; Issaka B; Ousmane S; Schwartz S; Tate AH; Pana A; Njanpop-Lafourcade BM; Nzeyimana I; Nse RO; Deghmane AE; Hong E; Brynildsrud OB; Novak RT; Meyer SA; Oukem-Boyer OOM; Ronveaux O; Caugant DA; Taha MK; Wang X;
Emerg Infect Dis; 2016 Oct; 22(10):1762-1768. PubMed ID: 27649262
[TBL] [Abstract][Full Text] [Related]
4. Emergence of serogroup X meningococcal disease in Africa: need for a vaccine.
Xie O; Pollard AJ; Mueller JE; Norheim G
Vaccine; 2013 Jun; 31(27):2852-61. PubMed ID: 23623866
[TBL] [Abstract][Full Text] [Related]
5. Microbiological and epidemiological investigation of the Neisseria meningitidis serogroup A epidemic in Niger in 2009: last wave before the introduction of the serogroup A meningococcal conjugate vaccine?
Collard JM; Maman Z; Abani A; Mainasara HB; Djibo S; Yacouba H; Maitournam R; Sidikou F; Nicolas P; Rocourt J; Jusot JF
Epidemiol Infect; 2011 Nov; 139(11):1656-60. PubMed ID: 21251346
[TBL] [Abstract][Full Text] [Related]
6. Phylogenetic relationships and regional spread of meningococcal strains in the meningitis belt, 2011-2016.
Topaz N; Caugant DA; Taha MK; Brynildsrud OB; Debech N; Hong E; Deghmane AE; Ouédraogo R; Ousmane S; Gamougame K; Njanpop-Lafourcade BM; Diarra S; Fox LM; Wang X
EBioMedicine; 2019 Mar; 41():488-496. PubMed ID: 30846392
[TBL] [Abstract][Full Text] [Related]
7. Future Directions for Meningitis Surveillance and Vaccine Evaluation in the Meningitis Belt of Sub-Saharan Africa.
Novak RT; Ronveaux O; Bita AF; Aké HF; Lessa FC; Wang X; Bwaka AM; Fox LM
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S279-S285. PubMed ID: 31671452
[TBL] [Abstract][Full Text] [Related]
8. Priorities for research on meningococcal disease and the impact of serogroup A vaccination in the African meningitis belt.
; Altmann D; Aseffa A; Bash M; Basta N; Borrow R; Broome C; Caugant D; Clark T; Collard JM; Djingarey M; Goldblatt D; Greenwood B; Griffiths U; Hajjeh R; Hassan-King M; Hugonnet S; Kimball AM; LaForce M; MacLennan C; Maiden MC; Manigart O; Mayer L; Messonnier N; Moisi J; Moore K; Moto DD; Mueller J; Nascimento M; Obaro S; Ouedraogo R; Page AL; Perea W; Pluschke G; Preziosi MP; Sow S; Stephens D; Stuart J; Thomson M; Tiendrebeogo S; Trape JF; Vernet G
Vaccine; 2013 Mar; 31(11):1453-7. PubMed ID: 23273967
[TBL] [Abstract][Full Text] [Related]
9. Emergence and control of epidemic meningococcal meningitis in sub-Saharan Africa.
Mohammed I; Iliyasu G; Habib AG
Pathog Glob Health; 2017 Feb; 111(1):1-6. PubMed ID: 28081671
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological changes in meningococcal meningitis in Niger from 2008 to 2011 and the impact of vaccination.
Collard JM; Issaka B; Zaneidou M; Hugonnet S; Nicolas P; Taha MK; Greenwood B; Jusot JF
BMC Infect Dis; 2013 Dec; 13():576. PubMed ID: 24313998
[TBL] [Abstract][Full Text] [Related]
11. Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.
Mustapha MM; Harrison LH
Hum Vaccin Immunother; 2018 May; 14(5):1107-1115. PubMed ID: 29211624
[TBL] [Abstract][Full Text] [Related]
12. Eliminating Meningococcal Epidemics From the African Meningitis Belt: The Case for Advanced Prevention and Control Using Next-Generation Meningococcal Conjugate Vaccines.
Alderson MR; LaForce FM; Sobanjo-Ter Meulen A; Hwang A; Preziosi MP; Klugman KP
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S274-S278. PubMed ID: 31671447
[TBL] [Abstract][Full Text] [Related]
13. Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine.
Topaz N; Kristiansen PA; Schmink S; Congo-Ouédraogo M; Kambiré D; Mbaeyi S; Paye M; Sanou M; Sangaré L; Ouédraogo R; Wang X
Microb Genom; 2020 Dec; 6(12):. PubMed ID: 33332261
[TBL] [Abstract][Full Text] [Related]
14. A Seroepidemiological Study of Serogroup A Meningococcal Infection in the African Meningitis Belt.
Manigart O; Trotter C; Findlow H; Assefa A; Mihret W; Moti Demisse T; Yeshitela B; Osei I; Hodgson A; Quaye SL; Sow S; Coulibaly M; Diallo K; Traore A; Collard JM; Moustapha Boukary R; Djermakoye O; Mahamane AE; Jusot JF; Sokhna C; Alavo S; Doucoure S; Ba el H; Dieng M; Diallo A; Daugla DM; Omotara B; Chandramohan D; Hassan-King M; Nascimento M; Woukeu A; Borrow R; Stuart JM; Greenwood B
PLoS One; 2016; 11(2):e0147928. PubMed ID: 26872255
[TBL] [Abstract][Full Text] [Related]
15. Gauging the epidemic potential of a widely circulating non-invasive meningococcal strain in Africa.
Brynildsrud OB; Eldholm V; Rakhimova A; Kristiansen PA; Caugant DA
Microb Genom; 2019 Aug; 5(8):. PubMed ID: 31454306
[No Abstract] [Full Text] [Related]
16. Meningococcal Meningitis Outbreaks in the African Meningitis Belt After Meningococcal Serogroup A Conjugate Vaccine Introduction, 2011-2017.
Fernandez K; Lingani C; Aderinola OM; Goumbi K; Bicaba B; Edea ZA; Glèlè C; Sarkodie B; Tamekloe A; Ngomba A; Djingarey M; Bwaka A; Perea W; Ronveaux O
J Infect Dis; 2019 Oct; 220(220 Suppl 4):S225-S232. PubMed ID: 31671449
[TBL] [Abstract][Full Text] [Related]
17. Genomic Epidemiology of Hypervirulent Serogroup W, ST-11 Neisseria meningitidis.
Mustapha MM; Marsh JW; Krauland MG; Fernandez JO; de Lemos AP; Dunning Hotopp JC; Wang X; Mayer LW; Lawrence JG; Hiller NL; Harrison LH
EBioMedicine; 2015 Oct; 2(10):1447-55. PubMed ID: 26629539
[TBL] [Abstract][Full Text] [Related]
18. [From genomics to surveillance, prevention and control: new challenges for the African meningitis belt].
Alonso JM; Bertherat E; Perea W; Borrow R; Chanteau S; Cohet C; Dodet B; Greenwood B; LaForce FM; Muros-Le Rouzic E; Teyssou R; Ouédraogo-Traoré R; Sow I
Bull Soc Pathol Exot; 2006 Dec; 99(5):404-8. PubMed ID: 17253061
[TBL] [Abstract][Full Text] [Related]
19. Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps.
LaForce FM; Djingarey M; Viviani S; Preziosi MP
Hum Vaccin Immunother; 2018 May; 14(5):1098-1102. PubMed ID: 28968148
[TBL] [Abstract][Full Text] [Related]
20. Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.
Mueller JE; Borrow R; Gessner BD
Expert Rev Vaccines; 2006 Jun; 5(3):319-36. PubMed ID: 16827617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]